Doctors doubt effect of new Covid-19 tablet

Covid-19 tablet treatment Lagevrio (molnupiravir), which the Danish Health Authority allowed on Thursday despite it having yet to be approved by the EMA, might not work at all, say Danish health experts.

Photo: Marius Renner

On Thursday, the Danish Health Authority allowed doctors in the country to use MSD's tablet treatment, Lagevrio (molnupiravir), to treat patients at risk of severe Covid-19 infections.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs